CTLA4 and neoplasm: The ferroptosis inducer ZVI-NP increases the anti-tumor effect by polarizing M2 macrophages to M1, decreasing the frequency of Treg, decreasing the expression of PD-L1 on tumor cells and PD-1/CTLA4 on CD8 + T cells, and increasing the anti-tumor immune response [141].